Acorda Therapeutics
ACOR
#11271
Rank
โ‚น76.7 M
Marketcap
โ‚น61.76
Share price
0.00%
Change (1 day)
-95.40%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -โ‚น22.63 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are โ‚น0.11 Billion. In 2023 the company made an earning of -โ‚น24.69 Billion a decrease over its 2022 earnings that were of -โ‚น0.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น22.63 Billion-8.34%
2023 -โ‚น24.69 Billion4848.63%
2022 -โ‚น0.5 Billion-93.25%
2021 -โ‚น7.39 Billion2.52%
2020 -โ‚น7.21 Billion-69.45%
2019 -โ‚น23.58 Billion-700.62%
2018 โ‚น3.92 B-118.02%
2017 -โ‚น21.79 Billion805.99%
2016 -โ‚น2.41 Billion-173.88%
2015 โ‚น3.25 B-6.58%
2014 โ‚น3.48 B20.19%
2013 โ‚น2.89 B18.7%
2012 โ‚น2.44 B-26.54%
2011 โ‚น3.32 B
2009 -โ‚น7.6 Billion10.65%
2008 -โ‚น6.87 Billion86.17%
2007 -โ‚น3.69 Billion68.1%
2006 -โ‚น2.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚น12.24 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.86 B-111.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-โ‚น7.15 Billion-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
โ‚น4.07 B-116.07%๐Ÿ‡บ๐Ÿ‡ธ USA